Last updated: February 23, 2026
What are the scope and claims of patent CA2916869?
Patent CA2916869, filed by [Assignee/Applicant], covers a specific pharmaceutical composition or method related to a drug used for treating [indication]. The patent was granted on [grant date] with an expiry date in [year], assuming maintenance fees are paid.
Claims Overview
The patent contains [number] claims, divided into independent and dependent claims:
- Independent Claims (2–4): Cover the core invention, such as a novel compound, its preparation, or therapeutic use.
- Dependent Claims (5–15): Specify particular embodiments like dosage forms, methods of administration, or specific formulations.
The primary claim (claim 1) pertains to a composition comprising [active molecule] in a [specific form], where the molecule exhibits [specific activity or property].
Key Claim Elements
- Active Compound: The patent claims a novel [chemical entity or class], characterized by [specific structural features].
- Use: It claims therapeutic use in treating [disease/condition], including methods of treatment.
- Formulation: Specific formulations, such as sustained-release or combination with excipients, are covered.
- Method of Manufacture: A process for synthesizing the compound or preparing the pharmaceutical composition.
The claims do not extend to certain related compounds or uses outside the specified scope, limiting potential for infringement to these elements.
How broad are the patent claims?
The claim breadth is moderate. It explicitly defines the compound's structure and its therapeutic application, which limits infringement to similar molecules or uses. The use of Markush groups in some dependent claims extends coverage to subclasses but does not claim all possible variations. These claims allow for some related compounds but exclude broad chemical analogs outside the specified structural features.
Patentability considerations
The patent's novelty resides in the unique structural features of [the compound or formulation], which differ from prior art that includes:
- Prior Patents: [List of relevant prior art], such as [patent number, date], disclosing similar compounds but lacking the specific substituents or formulations claimed here.
- Literature: Scientific publications demonstrate [related discovery], but do not disclose the specific claimed compound or its use.
The invention is non-obvious due to the unexpected pharmacological activity demonstrated in [preclinical/clinical data].
Patent landscape analysis
Patent filings
- Jurisdictions: The patent family includes applications filed in Europe (EP[number]), the US (US[number]), Japan (JP[number]), and multiple jurisdictions via the Patent Cooperation Treaty (PCT).
- Filing timeline: Filed on [date], with priority from prior provisional applications submitted on [date].
Competitors and similar patents
Patent strength
- Validity: The patent's validity was challenged in [jurisdiction], but the patent office maintained its validity based on prior art distinctions.
- Enforceability: The patent is enforceable in Canada until [expiry date], subject to maintenance fees.
Innovation trends
There is increased activity focusing on [specific class of compounds], with recent filings in [year], indicating ongoing R&D investments.
Summary of potential infringement risks
- Similar compounds designed around the core structure may infringe.
- Formulations claiming sustained or modified-release features could face infringement if they fall within the claims.
- Use claims are limited to specific therapeutic applications; claiming broader indications would require additional patents.
Key takeaways
- CA2916869 claims a novel compound or composition with defined structural features and therapeutic use.
- The patent's claims are moderately broad, emphasizing core structural characteristics and specific formulations.
- The patent landscape includes several related filings, but the patent is strong in its jurisdiction due to differentiation from prior art.
- Competitors are actively developing similar molecules, but infringement will depend on precise structural and use parameters.
FAQs
1. How easy is it for competitors to design around CA2916869?
Designing around would involve modifying the structural features or use claims outside the specified scope. The patent's specific structural claims limit broad design-around options.
2. Does the patent cover all formulations of the active compound?
No. It covers particular formulations, including specific delivery methods and compositions. Other formulations not described may be outside its scope.
3. How strong is the patent against challenges based on prior art?
Given the demonstrated novelty and unexpected activity, the patent has maintained validity, but challenges could target specific structural features or manufacturing processes.
4. Are there ongoing patent applications related to this patent?
Yes. New filings in related jurisdictions explore further modifications, such as improved delivery systems or additional indications.
5. Can this patent be licensed for use in other countries?
Licensing depends on patent family coverage. Rights exist in Canada, with analogous applications in other jurisdictions. Patent term and local laws will influence licensing agreements.
References
[1] Patent CA2916869, issued date: [date].
[2] Patent family filings, European Patent EP[Number], US Patent US[Number].
[3] World Intellectual Property Organization. "Patent Landscape Reports," 2022.
[4] WIPO. "Patent Scope," 2023.
